Header Logo


Andrew South to Peptidyl-Dipeptidase A

This is a "connection" page, showing publications Andrew South has written about Peptidyl-Dipeptidase A.
Connection Strength

  1. Cohen JB, Hanff TC, Bress AP, South AM. Relationship Between ACE2 and Other Components of the Renin-Angiotensin System. Curr Hypertens Rep. 2020 06 26; 22(7):44.
    View in: PubMed
    Score: 0.762
  2. South AM, Brady TM, Flynn JT. ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective. Hypertension. 2020 07; 76(1):16-22.
    View in: PubMed
    Score: 0.755
  3. South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. 2020 05 01; 318(5):H1084-H1090.
    View in: PubMed
    Score: 0.750
  4. South AM, Tomlinson L, Edmonston D, Hiremath S, Sparks MA. Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic. Nat Rev Nephrol. 2020 06; 16(6):305-307.
    View in: PubMed
    Score: 0.190
  5. Sparks MA, South A, Welling P, Luther JM, Cohen J, Byrd JB, Burrell LM, Batlle D, Tomlinson L, Bhalla V, Rheault MN, Soler MJ, Swaminathan S, Hiremath S. Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19. Clin J Am Soc Nephrol. 2020 May 07; 15(5):714-716.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.